Showing results (1-10 of 540) with videos related to
Sort By:
Pageof 54
Biologics : Targets & Therapy|February 12, 2021
Convalescent Plasma for the Treatment of Severe COVID-19Massimo Franchini, Giancarlo Maria LiumbrunoJournal of Thrombosis and Thrombolysis|May 22, 2014
Solvent/detergent plasma: pharmaceutical characteristics and clinical experienceGiancarlo Maria Liumbruno, Massimo FranchiniClinical Chemistry and Laboratory Medicine|May 8, 2013
ABO blood group: old dogma, new perspectivesMassimo Franchini, Giancarlo Maria LiumbrunoJournal of Thrombosis and Thrombolysis|November 16, 2013
Hemostasis, cancer, and ABO blood group: the most recent evidence of associationGiancarlo Maria Liumbruno, Massimo FranchiniExpert Review of Proteomics|April 12, 2013
Proteomic analysis of venous thromboembolism: an updateGiancarlo Maria Liumbruno, Massimo FranchiniDiagnosis (Berlin, Germany)|March 2, 2021
Potential mechanisms of action of convalescent plasma in COVID-19Massimo Franchini, Claudia Glingani, Giancarlo Maria LiumbrunoEuropean Journal of Haematology|May 14, 2021
COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndromeMassimo Franchini, Giancarlo Maria Liumbruno, Mario PezzoExpert Review of Hematology|March 3, 2021
Hemostatic therapy as a management strategy for acquired hemophilia: what does the future hold?Massimo Franchini, Michele Schiavulli, Giancarlo Maria LiumbrunoLife (Basel, Switzerland)|April 30, 2021
The Three Pillars of COVID-19 Convalescent Plasma TherapyMassimo Franchini, Giancarlo Maria Liumbruno, Giorgio Piacentini, et al.Expert Review of Hematology|February 20, 2015
Solvent/detergent-treated plasma: a tale of 30 years of experienceGiancarlo Maria Liumbruno, Giuseppe Marano, Gioia Grazzini, et al.Pageof 54